How Our Obsession With Being Thin Is Driving Pharma Profits
January 26, 2024
288,602
3,255
236
1.21%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Originals Episodes Around January 26, 2024
See what was published immediately before and after this episode.
6:26Now PlayingHow Our Obsession With Being Thin Is Driving Pharma Profits
Segments
YouTube Description
as posted by the channelEach January, weight loss is top of mind for millions of people. These days, there's a new solution for many: Ozempic. The success of the drug and its sibling Wegovy has turned Novo Nordisk into Europe’s biggest company. But Eli Lilly’s newest GLP-1 drug, Zepbound, could take a big bite out of the market. Amid rising obesity rates and increasing demand for weight-loss solutions, valuations for both pharmaceutical giants are soaring.
Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months
#weightloss #pharma #business #Ozempic #Wegovy #Zepbound
Check out the Big Take podcastThe Pharmaceutical Rivalry Behind the WeightLoss Drug Boom 👉
--------
Like this video? Subscribe
Become a Quicktake Member for exclusive perks
Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.
Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.
Visit our partner channel Bloomberg Quicktake for global news and insight in an instant.
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.